Skip to content

Prevalence and Risk Factors for Hypertension and Recoarctation in Patients Operated for Aortic Coarctation

PRECOHA ; Prevalence and Risk Factors for Hypertension and Recoarctation in Patients Operated for Aortic Coarctation After Early Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07499609
Acronym
PRECOHA
Enrollment
901
Registered
2026-03-30
Start date
2025-10-01
Completion date
2026-01-01
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Coarctation, Cardiac Surgery, Cohort Studies, Death, Hypertension, Infant, Newborn, Mortality, Postoperative Complications, Reoperation, Retrospective Studies, Risk Factors

Keywords

Cohort Studies Retrospective Studies, Risk Factors, mortality, Survival Analysis

Brief summary

Multicenter Retrospective Study Over a 14-Year Period From 2010 to 2024

Detailed description

Inclusion of all neonates and infants who underwent surgical repair of aortic coarctation within the first year of life in one of the five participating surgical centers. From antenatal data to postoperative complications. Very large table. Event-free survival (events: death, recoarctation, cardiac reinterventions, hypertension) Description of patients who developed recoarctation Univariate and multivariate analysis of determinants of recoarctation (+/- death): patients with recoarctation versus others (excluding those who died without recoarctation). Main Predictive Factors and Primary Criteria to Be Tested: Antenatal diagnosis of coarctation: yes/no Prematurity: yes/no and subgroups (24-32 weeks vs. 32-37 weeks vs. term) Intrauterine growth restriction (IUGR): yes/no; IUGR vs. small for gestational age vs. normal weight Birth weight \< 2500 g vs. \> 2500 g Prostaglandin infusion: yes/no Duration of prostaglandin infusion (days) Ventricular septal defect (VSD): yes/no Bicuspid aortic valve: yes/no Hemodynamic failure: yes/no Aortic valve size: \< -2 Z-score Horizontal aorta \< 3.6 mm vs. \> 3.6 mm CT scan performed: yes/no Age at surgery: \< or \> 1 month Surgical technique: patch vs. simple/extended Crafoord repair Associated procedure: yes/no Length of ICU stay (days) Postoperative cardiovascular complication: yes/no Postoperative isthmic peak velocity: \< or \> 2 m/sec Data Collection Excel database including 934 patients from 5 centers. 127 columns from A (Anonymization number) to DX (Date of hypertension diagnosis). Primary endpoint: Prevalence and morbidity/mortality. Data divided into 13 sections: Sociodemographic data: Follow-up center, responsible physician Antenatal data: Follow-up and echocardiography results Delivery: Neonatal clinical presentation: Diagnostic echocardiography: Preoperative CT scan if performed: First intervention: Post-intervention echocardiography Second intervention if performed: Recoarctation with surgical intervention: Recoarctation with catheter intervention Last follow-up data: Weight, height, blood pressure, date of last visit, last news Date of death Exercise test results if available:

Interventions

None listed

Sponsors

Institut Saint Pierre
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Inclusion of all neonates and infants who underwent surgical repair of aortic coarctation within the first year of life in one of the five participating surgical centers. Among associated intracardiac lesions, patients with ventricular septal defect (VSD), atrial septal defect (ASD), bicuspid aortic valve, and persistent left superior vena cava are also included. \-

Exclusion criteria

Children with complex congenital heart disease (e.g., transposition of the great arteries, double outlet right ventricle, single ventricle, truncus arteriosus, interrupted aortic arch) are excluded. Patients that underwent angioplasty as first intervention will also be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of recoarctation after coarctation surgeryUp to 14 years post-surgery (2011-2025).Prevalence of recoarctation among patients operated for aortic coarctation before one year of age. Recoarctation is defined by a cardiac catheterisme that showed a reduction of the lumen avec aortic isthmus of 50% and/or a peak-to-peak gradient \> 20mmHg at the level of the recoarctation. Survival analysis without recoarctation Percentage of patients and Kaplan-Meier survival curves.

Secondary

MeasureTime frameDescription
global survival in patient operated of coarctation2011-2025 (14 yearsProportion of patient that died (what ever the cause) after their surgery and during the follow up.
Proportion of systemic hypertension at last follow up in patient operated of aortic coarctation2011-2015 (14 years)Regarding the systemic hypertension outcome, patients were classified as hypertensive at their last out-patient visit if they presented with diastolic and/or systolic blood pressure above the 95th percentile (according to sexe, age and height) or if they were under antihypertensive drugs To establish the onset date of systemic hypertension, outpatient cardiology visits were retrospectively reviewed from the most recent to the earliest encounter to identify: 1) the first abnormal blood pressure value and/or 2) the introduction of a hypertensive drugs.
Predictors of recoarctationUp to 14 years post-surgeryOutcomes associated to recoarctation will be assessed using univariate and multivariate logistic regression models. Variables considered include demographic, anatomical, and surgical characteristics (e.g., prematurity, birth weight, prostaglandin use, surgical technique). Comparisons will be made between patients who developed recoarctation and those who did not, excluding patients who died without recoarctation Analysis of potential predictive factors using univariate and multivariate models.

Countries

France

Contacts

STUDY_DIRECTOROscar WERNER, Dr WERNER

non afilié

PRINCIPAL_INVESTIGATORcharlotte duseigneur

institu saint pierre

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026